Abstract
In present study, we investigated if inflammatory mediators secreted by the inflamed colonic mucosa from patients with Crohn's disease and ulcerative colitis had the ability to up-regulate the expression of two adhesion molecules, E-selectin and intercellular adhesion molecule-1. Organ culture techniques and enzyme-linked immunoassays were used to quantify these up-regulations in human umbilical vein endothelial cells. Our results show that, in Crohn's disease patients, the expression of E-selectin was up-regulated 5.5-fold over control values and intercellular adhesion molecule-1 expression was increased 2.4-fold. In ulcerative colitis patients, E-selectin expression was up-regulated twofold over controls with only a 1.5-fold increase in intercellular adhesion molecule-1 expression. Histologically, there was no difference in the degree of inflammation between the two disease groups. Sulfasalazine, in a dose-dependent manner, inhibited E-selectin expression up to 58% and intercellular adhesion molecule-1 up to 62% when stimulated by lipopolysaccharide. The up-regulation of E-selectin and intercellular adhesion molecule-1 may play an important role in mediating the inflammatory process in inflammatory bowel disease. The observed difference between Crohn's disease and ulcerative colitis may reflect differences in inflammatory cell infiltrates or the histopathological differences between the two diseases.
Similar content being viewed by others
References
Bevilacqua MP, Nelson RM: Selectins. J Clin Invest 91:379–387, 1993
Jutila MA: Leukocyte traffic to sites of inflammation. APMIS 100:191–201, 1992
Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 70:427–451, 1990
Lasky LA: Selectin: Interpreters of cell-specific carbohydrate information during inflammation. Science 258:964–969, 1992
Doukas J, Pober JS: IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. J Immunol 145:1727–1733, 1990
Dustin ML, Rothelin R, Bhan AK, Dinarello CA, Springer TA: Induction by IL-1 and interferon-gamma: Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 137:245–254, 1986
Malizia G, Calabrese A, Cotton M, Raimondo M, Trejdosiewicz LK, Smart CJ, Oliva L, Pagliaro L: Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 100:150–156, 1991
Nakamura S, Ohtani H, Watanabe Y, Fukushima K, Matsumoto T, Kitano A, Kenzov K, Naguga H:In situ expression of the cell adhesion molecules in inflammatory bowel disease. Lab Invest 69:77–85, 1993
Koizumi M, King N, Lobb R, Benjamin C, Podolsky DK: Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103:840–847, 1992
Matts SGF: The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 30:393–407, 1961
Sharon P, Drab EA, Linder JS, Weidman SW, Rubin DB: The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle distribution. J Lab Clin Med 119:99–107, 1992
Sharon P, Ligumsky M, Rachmilewitz D, Zor U: Role of prostaglandin in ulcerative colitis; enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 75:638–640, 1978
Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Pariollo JE: Endotoxemia in human septic shock. Chest 99:169–175, 1991
Peppercorn MA: Sulfasalazine pharmacology, clinical use, toxicity and related new drug development. Ann Intern Med 3:377–386, 1984
Lau AL, Lam NP, Piscitelli SC, Wilkes L, Danziger LA: Clinical pharmacokinetics of metronidazole and other nitromidazole anti infectives. Clin Pharmacokinet 23:328–364, 1992
Kivisto KT: A review of assay methods for cyclosporin. Clin Pharmacokinet 23:173–190, 1990
Ahrenstedt O, Knutson L, Nilsson B, Nilssor-Ekdahl K, Odlind B, Hallgren R: Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med 322:1345–1349, 1990
MacDermott RP, Nash GS, Auer IO, Shlien R, Lewis BS, Madassery J, Nahm MH: Alterations in serum immunoglobulin G subclass in patients with ulcerative colitis and Crohn's disease. Gastroenterology 96:764–768, 1989
Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan R: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illness. Gastroenterology 100:1590–1596, 1991
Kusugumi K, Youngman KR, West GA, Fiocchi C: Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis and control. Gastroenterology 97:1–9, 1989
MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A: Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 81:301–305, 1990
Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin-1 in inflammatory bowel disease—enhanced production during active disease. Gut 31:686–689, 1990
Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AM, More L, Sim R, Pittilo RM, Rowles PM, Hudson M, Lewis AAM, Pounder RE: Granulomatous vasculitis in Crohn's disease. Gastroenterology 100:1279–1287, 1991
Author information
Authors and Affiliations
Additional information
Support by The Crohn's and Colitis Foundation of America.
Rights and permissions
About this article
Cite this article
Pooley, N., Ghosh, L. & Sharon, P. Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis. Digest Dis Sci 40, 219–225 (1995). https://doi.org/10.1007/BF02063969
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02063969